EEF1A1 and B-cell chronic lymphocytic leukemia: The research on aptamer therapy for CLL is still in its initial stage, and researchers have found higher levels of EEF1A1 in lymphocytes of CLL patients, so they have screened it as a therapeutic target to obtain aptamers for CLL.